Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinomaTejas Jammihal, Sachet A. Shukla, Yasmin Nabil Laimon et al.|Nature Cancer|2025Cited by 32
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaChris Labaki, David A. Braun, Eddy Saad et al.|Journal of Clinical Oncology|2025Cited by 14
831 AXL Receptor Tyrosine Kinase Expression in Metastatic Renal Cell Carcinoma: Insights from the METEOR trialYasmin Nabil Laimon, Sabina Signoretti, Paul Morgan et al.|Laboratory Investigation|2025Cited by 2
1891P Determinants of exceptional response to immune checkpoint inhibition in metastatic clear cell renal cell carcinomaR.M. Saliby, D.A. Braun, Tejas Jammihal et al.|Annals of Oncology|2023Cited by 1
Cellular and molecular determinants of limited anti-tumor immunity in chromophobe renal carcinoma (ChRCC).Chris Labaki, David A. Braun, Michel Alchoueiry et al.|Journal of Clinical Oncology|2024Cited by 1